FDA says muscle, joint pain creams can cause burns

(AP)—The Food and Drug Administration is warning consumers about rare chemical burns reported by people using popular pain relief products like Bengay, Icy Hot and Flexall.

The over-the-counter products are designed to provide short-term relief from minor muscle and joint aches and pains. But regulators say they have received reports of skin injuries ranging from first- to third-degree chemical burns caused by the products. Some of burns have required hospitalization, according to a notice posted to FDA's website.

The agency says consumers should stop using the if they experience signs of , such as pain, swelling or blistering of the skin. Doctors should instruct patients on how to use the products, which come in lotions and patches, correctly.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

US warns of drugs in Reumofan dietary supplements

Aug 21, 2012

(AP) — The U.S. Food and Drug Administration is warning consumers not to use Reumofan dietary supplements, after receiving reports of bleeding, stroke and death among Americans taking the Mexico-manufactured pills.

FDA cracks down on hydrocone products

Sep 29, 2007

The U.S. Food and Drug Administration says it will start taking enforcement action against companies marketing unapproved hydrocodone products.

Heat halts pain inside the body

Jul 05, 2006

The old wives' tale that heat relieves abdominal pain, such as colic or menstrual pain, has been scientifically proven by a UCL (University College London) scientist, who will present the findings today at the Physiological ...

Recommended for you

Pyridoxine-doxylamine drug safety data lacking

15 hours ago

(Medical Xpress)—The most commonly prescribed drug for pregnant women suffering from morning sickness in their first trimester does not prevent birth defects even though drug safety data says it does, according to research ...

FDA approves new type 2 diabetes drug

Apr 15, 2014

(HealthDay)—Millions of Americans with type 2 diabetes have a new treatment option with the U.S. Food and Drug Administration's approval Tuesday of a once-weekly injectable drug, Tanzeum.

User comments